Table 2.
Inflammation covariates by prostate cancer status, 2009–2010 NHANES data.
Variables and factors | Percent by prostate cancer status | Unadjusted odds ratios (%95 CI) | ||
---|---|---|---|---|
No prostate cancer | Has prostate cancer | |||
C-reactive protein | Low grade inflammation (≤3 mg/ml) | 71.6 | 72.8 | OR = 1.061 (1.059–1.064) Men with low grade inflammation by CRP measure had slightly higher odds of having prostate cancer |
High grade inflammation (>3 mg/ml) | 28.4 | 27.2 | ||
Inflammation from infection | No inflammation from infection | 68.9 | 35.0 | OR = 1.029 (1.029–1.029) Men with no inflammation from infection had slightly greater odds of not having prostate cancer |
Inflammation from infection | 31.1 | 65.0 | ||
Drug use to control inflammation | No drugs taken for inflammation | 14.6 | 18.7 | OR = 1.330 (1.324–1.336) Men who were not taking drugs to control inflammation had greater odds of having prostate cancer |
Drugs taken for inflammation | 85.4 | 81.3 | ||
Existing disease causing inflammation | No disease causing inflammation | 63.4 | 54.0 | OR = 1.031 (1.030–1.031) Men with no inflammation from disease had greater odds of not having prostate cancer |
Disease causing inflammation | 36.6 | 46.0 |